htm PRESS RELEASE EdgarFilingEXHIBIT 99. Bergstrom currently serves as Executive Vice President, Head of Research and Development at Relay Therapeutics, Inc. 1Cellectis Announces the Appointment of Axel-Sven Malkomes Dr.
💼 Business Developments:
❌ Partnership/Collaboration: Not reported
✅ Acquisition Activity
❌ Licensing Agreement: Not reported
❌ Regulatory Milestone: Not reported
❌ Leadership Updates: Not reported
📞 Contact Information:
Media Contact: s: Pascalyne Wilson, Director, Communications, +33776991433, media@cellectis.com
🌍 Cellectis (CLLS) - Form 6-K Filing
Filing Date: 2022-06-28
Accepted: 2022-06-28 16:45:32
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: